Neoadjuvant Lazertinib With or Without Chemotherapy for Patients With EGFR-mutated Resectable Non-small Cell Lung Cancer
Clinical trial NCT06268210 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06268210
- Sponsor
- Yonsei University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-07
- Primary completion
- 2028-05-01
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.